Amarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of Vascepa® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-IT® Outcomes Trial

Bud Bilanich
Success Coach

Don Feiler
Brand Engagement

Julia Laurin
Medication Adherence

Adrienne Stevens, EdD
HCP Insights

Joe Jackson
Healthcare Engagement Solutions

Tony Schueth, MS
EHR Strategies

Brenda Snow
Authentic Patient Voice

Sarah Caldwell
Data & Analytics